Pyraclostrobin-d6

• UNSPSC Description:

  Pyraclostrobin-d6 is deuterium-labeled Pyraclostrobin (HY-N6626)[1].

• Target Antigen:

  AMPK; Autophagy; Bacterial; Bcl-2 Family; Beclin1; Fungal; Isotope-Labeled Compounds; mTOR

• Type:

  Isotope-Labeled Compounds

• Related Pathways:

  Anti-infection;Apoptosis;Autophagy;Epigenetics;Others;PI3K/Akt/mTOR

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  others

• Smiles:

  ClC1=CC=C(N2N=C(C=C2)OCC3=C(C=CC=C3)N(C(OC([2H])([2H])[2H])=O)OC([2H])([2H])[2H])C=C1

• Molecular Weight:

  393.85

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.|[2]Smith K A, et al. Soil and environmental analysis[M]. Marcel Dekker Incorporated, 2000.|[3]Fan T W M, et al. Stable isotope-resolved metabolomics and applications for drug development[J]. Pharmacology & therapeutics, 2012, 133(3): 366-391.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported